IAN
KYMR icon

Integrated Advisors Network’s Kymera Therapeutics KYMR Stock Holding History

Integrated Advisors Network’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,218
Closed -$294K – 737
2024
Q3 		$294K Buy
+6,218
New +$275K 0.01% 606
2024
Q2 		– Sell
-6,218
Closed -$250K – 720
2024
Q1 		$250K Buy
+6,218
New +$222K 0.01% 636
2022
Q2 		– Sell
-6,218
Closed -$263K – 702
2022
Q1 		$263K Hold
6,218
– – 0.02% 573
2021
Q4 		$395K Hold
6,218
– – 0.02% 462
2021
Q3 		$365K Sell
6,218
-7,500
-55% -$435K 0.02% 470
2021
Q2 		$665K Buy
+13,718
New +$596K 0.05% 305

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Integrated Advisors Network's KYMR Position: Q4 2024 in Review

Integrated Advisors Network sold out of Kymera Therapeutics (KYMR) in Q4 2024, closing a stake of 6,218 shares — an estimated $294K sold.

Integrated Advisors Network first reported a position in KYMR in Q2 2021 and held it in 6 quarters. The position peaked at $665K in Q2 2021. 180 funds tracked by Wall St. Rank hold KYMR as of Q4 2024.

  • Integrated Advisors Network reported no remaining Kymera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Integrated Advisors Network sold 6,218 Kymera Therapeutics shares in Q4 2024, an estimated $294K.
  • Integrated Advisors Network first reported a position in Kymera Therapeutics in Q2 2021 and held it in 6 quarters.
  • Integrated Advisors Network's Kymera Therapeutics position peaked at $665K in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2024.

Based on Integrated Advisors Network's 13F filing for Q4 2024, filed 25 Feb 2025.